[HTML] sciencedirect.com

[HTML][HTML] Mefunidone ameliorates lipopolysaccharide-induced acute lung injury through inhibiting MAPK signaling pathway and enhancing Nrf2 pathway

TT Yao, Y Zhang, RL He, X Lv, YJ He, MY Li… - International …, 2022 - Elsevier
Abstract Background and Objective Acute lung injury (ALI) is a life-threatening disease
which has high mortality and lacks effective pharmacological treatments. Excessive …
被引用次数：5 相关文章

Mefunidone ameliorates lipopolysaccharide-induced acute lung injury through inhibiting MAPK signaling pathway and enhancing Nrf2 pathway

TT Yao, Y Zhang, RL He, X Lv, YJ He… - International …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and objective Acute lung injury (ALI) is a life-threatening disease which has
high mortality and lacks effective pharmacological treatments. Excessive inflammation and …

Mefunidone ameliorates lipopolysaccharide-induced acute lung injury through inhibiting MAPK signaling pathway and enhancing Nrf2 pathway.

TT Yao, Y Zhang, RL He, X Lv, YJ He, MY Li… - International …, 2022 - europepmc.org
Methods We investigated the effects of MFD on LPS-induced ALI mouse model and LPS-
stimulated immortalized mouse bone marrow-derived macrophages (iBMDMs). Results MFD …